Mursel Sali

6PUBLICATIONS
62CO-AUTHORS
Molecular targetsHaematological tumoursPredictive and prognostic markersCancer cell biologyNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 25, 2026
Real-World Outcomes of CDK4/6 Inhibitors in Germline BRCA1/2-Mutated Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study.

|Jun 11, 2026
Association Between Blood Transfusion and Survival Outcomes in Metastatic Cutaneous Melanoma Treated with Nivolumab.

|Mar 28, 2026
Integrating Tumor Biology and Host Factors in mCRPC: The Prognostic Value of 'Time to Castration Resistance', Systemic Inflammation, and Comorbidity Burden in Patients Treated with Enzalutamide.

Seda Sali, Arife Ulaş, Sibel Oyucu Orhan

|Dec 31, 2025
Prognostic Value of Histological Subtypes and Clinical Factors in Non-Endemic Nasopharyngeal Carcinoma: A Retrospective Cohort Study.

Seda Sali, Candan Demiröz Abakay, Mürsel Sali

|Jul 25, 2025
Survival Outcomes in Patients with Squamous Cell Carcinoma of the Urinary Bladder: A Propensity Score-Matched Analysis.

Alper Coskun, Ahmet Bilgehan Sahin, Selva Kabul

|Jun 30, 2025
Primary neuroendocrine tumors of the breast according to the WHO 2019 classification; real life experiences of rare tumor types of the breast.

Seda Sali, Mursel Sali, Burcu Caner

Pageof 1

Frequent Collaborators

4 joint publications

Seda Sali

4 joint publications

Alper Coskun

4 joint publications

Adem Deligonul

4 joint publications

Ahmet Bilgehan Sahin